CYTK:NASDAQ
Cytokinetics, Inc.
$61.52
arrow_upward
+0.29%(+0.18) 1D
Oct 7, 1:42:17 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$61.08
High
$62.05
Low
$60.15
Mkt. cap
8.55B
Avg. vol.
2.15M
Volume
1.16M
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$61.08
High
$62.05
Low
$60.15
Mkt. cap
8.55B
Avg. vol.
2.15M
Volume
1.16M
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Stock Traders Daily
·
16 hours ago
(CYTK) Risk Channels and Responsive Allocation
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com